Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4000 participants.
Also called NCT07143149
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 4,000 participants
- Sponsor
- Registry
-
NCT07143149
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07143149. Randomized; single masking; primary purpose prevention. Start 2025-11-03 (actual); primary completion 2028-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China
- Condition
- Ischemic Stroke
- Intervention (Device)
- the Intelligent Lipid Management Decision-support System
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07143149- Content hash
fb522e93651c370a9e6aa8e29aca491358b902dd84cca99cca1f1030e340b8f5